52MO A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC). - Vogel, A.; Boeck, S.; Waidmann, O.; Bitzer, M.; Wenzel, P.; Belle, S.; Springfeld, C.; Schulze, K.; Weinmann, A.; Lindig, U.; Trautwein, C.; Dechow, T.; et al. (Annals of Oncology, 2022)